4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-22-003372
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 122,374 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FARR KEVIN M · CHIEF FINANCIAL OFFICER
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-17 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +122,374 | 122,374 | D |
Loading xslF345X03/wf-form4_164556897219267.xml…